Skip to main content

Posts

What did the ISCHEMIA trial teach us about Heart Blockages?

 Heart blockages occur when the arteries carrying blood to the heart start narrowing. The heart receives less oxygen than what is required. In the early stages, this reduced supply is mild and inconsistent, which is why symptoms can be inconsistent and hard to pinpoint. Do consult a doctor if you are experiencing the following symptoms: 1.       Fatigue 2.       Shortness of breath during activities that have not seemed difficult before. 3.       Pressure in the middle of the chest. In a landmark trial conducted by the researchers from NYU Grossman School of Medicine and Stanford University, they present some important findings related to heart blockages and their treatment. Background of the ISCHEMIA study Funded by the National Heart, Lung, and Blood Institute, the ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial studied patients with...

Angioplasty vs. Placebo: The ORBITA Trial Shakes the Foundations of Stable Angina Treatment

  What the Landmark ORBITA Trial Means for Patients, Cardiologists and the Future of Heart  Disease Management A Landmark Study That Sent Shockwaves Through Cardiology On 2 November 2017, The Lancet, one of the world's most prestigious medical journals, published a landmark clinical trial that has challenged one of the most deeply held beliefs in modern cardiology. The study, known as ORBITA (Objective Randomised Blinded Investigation with Optimal Medical Therapy of Angioplasty in Stable Angina), has generated intense debate among cardiologists across the world and may ultimately reshape the management of patients with stable coronary artery disease. For nearly four decades, angioplasty has been considered the preferred treatment for relieving chest pain in patients with stable angina. Although previous clinical trials had already demonstrated that angioplasty does not reduce the risk of future heart attacks or improve survival in stable patients, many physicians continued to ...

Latest EECP Clinical Research in 2026: What Patients Should Know

EECP in 2026: What the Latest Clinical Research Tells Us Enhanced External Counterpulsation, widely known as EECP treatment, is gaining fresh clinical validation in 2026. A new study published in Frontiers in Cardiovascular Medicine has strengthened the evidence base for this non-invasive cardiac care option. Heal Your Heart, one of India's reputed EECP treatment centers, has closely followed this research. It reflects a growing global recognition of EECP therapy as an effective tool in cardiac rehabilitation. Led by Dr. S. Ramasamy, an internationally renowned non-invasive cardiac care expert, Heal Your Heart was founded with a clear vision. That vision was to offer patients a scientifically backed, drug-free, surgery-free path to cardiovascular health. Dr. Ramasamy's decades of specialization in EECP therapy have positioned the center as a trusted name in evidence-based cardiac care. What the 2026 Study Found The February 2026 study followed 798 patients with acute ...

Reading Between the Numbers: Heart Health in Focus

  Tamil Nadu’s cardiovascular mortality share rose from 21% of all deaths in 1990 to 36% in 2016, placing the state among the top three in India for cardiovascular disease (CVD) mortality. Ischaemic heart disease now accounts for the single largest share of years of life lost to premature death in the state. Overall mortality patterns across Tamil Nadu have remained relatively steady over the past decade, but this stability conceals an uncomfortable reality: heart disease continues to claim a growing and disproportionate share of that fixed number. Non-communicable diseases are responsible for more than 75% of all deaths in the state, and hypertension alone contributes to nearly 22% of them. The figures point to a population ageing into risk faster than its healthcare-seeking behaviour is adapting. Reading between these numbers reveals what they do not state directly: cardiovascular disease in Tamil Nadu is not an emerging threat. It is an established one, and the gap lies in e...

குதிரையின் வேகம்... மனிதனின் இதயம்! அறுவை சிகிச்சை இல்லாத மாற்றுப் பாதை

  ஒரு குதிரையின் தசைகளுக்குச் செல்லும் இரத்த ஓட்டம் தடைபட்டால், அந்த இதயத்தால் வேகமாக ஓட முடியாது. அதேபோலத்தான், மனித இதயத்தின் தமனிகள் (Coronary arteries) சுருங்கி அடைப்பு ஏற்படும்போது, இதய தசைகளுக்குத் தேவையான ஆக்ஸிஜன் நிறைந்த இரத்தம் கிடைப்பதில்லை. இதையே நாம் கொரோனரி தமனி நோய் (Coronary Artery Disease - CAD) என்கிறோம். இதய ஆரோக்கியத்தைக் கெடுக்கும் முக்கிய ஆபத்துக் காரணிகள்: உயர் இரத்த அழுத்தம் (Hypertension): இரத்த நாளங்களின் சுவர்களை சேதப்படுத்தி, கொழுப்பு படிவதை (Plaque) வேகப்படுத்துகிறது. கொழுப்பு மாறுபாடு (Dyslipidemia): எல்.டி.எல் (LDL) என்னும் கெட்ட கொழுப்பு நேரடியாக இரத்த நாளங்களில் அடைப்பை ஏற்படுத்துகிறது. டைப் 2 நீரிழிவு (Type 2 Diabetes): சர்க்கரையின் அளவு அதிகரிப்பதால் இரத்த நாளங்கள் சேதமடைகின்றன. புகையிலை பயன்பாடு: மாரடைப்பு ஏற்படுவதற்கான மிக முக்கியமான நேரடி காரணி. உடலுழைப்பற்ற வாழ்க்கை: புதிய மாற்று இரத்த நாளங்கள் (Collateral vessels) உருவாவதைத் தடுக்கிறது. முக்கிய எச்சரிக்கை: மேற்கத்திய நாடுகளுடன் ஒப்பிடும்போது, இந்தியர்களுக்கு 10 முதல் 15 ஆண்டுகள் முன்னதா...